Pages that link to "Q110910889"

The following pages link to Ans C. P. Wiesfeld (Q110910889):

Displaying 35 items.

• Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features (Q24294249) (← links)
• Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans (Q24310498) (← links)
• Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study (Q28238424) (← links)
• Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy (Q28304094) (← links)
• Genetic aspects of atrial fibrillation (Q36142161) (← links)
• Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy (Q36330386) (← links)
• Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial (Q38386641) (← links)
• Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members (Q41144205) (← links)
• Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator (Q44541238) (← links)
• Surgical vs. transcatheter pulmonary vein isolation as first invasive treatment in patients with atrial fibrillation: a matched group comparison (Q45423432) (← links)
• Determinants and outcome of amiodarone-associated thyroid dysfunction (Q45832551) (← links)
• Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study (Q46775454) (← links)
• Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation (Q47914576) (← links)
• Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers (Q47972719) (← links)
• Feasibility and outcome of epicardial pulmonary vein isolation for lone atrial fibrillation using minimal invasive surgery and high intensity focused ultrasound (Q50247612) (← links)
• Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients (Q51094970) (← links)
• Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients (Q51156774) (← links)
• Favorable long-term outcome of Maze surgery in patients with lone atrial fibrillation. (Q51220834) (← links)
• Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation. (Q51222306) (← links)
• Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. (Q53228124) (← links)
• Obesity is associated with impaired long-term success of pulmonary vein isolation: a plea for risk factor management before ablation. (Q54979263) (← links)
• Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene (Q57200485) (← links)
• High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics (Q57200490) (← links)
• Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. (Q64934138) (← links)
• A family with Andersen-Tawil syndrome and dilated cardiomyopathy (Q79317024) (← links)
• Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function (Q79855401) (← links)
• Key questions are helpful to prevent an unnecessary pulmonary veins isolation ablation procedure (Q81589764) (← links)
• A family with abnormal electrocardiograms: part I (Q81773477) (← links)
• Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study (Q82327612) (← links)
• Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy (Q83433276) (← links)
• Brugada syndrome with ST-segment elevation in the lateral leads (Q83943819) (← links)
• New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy (Q84754813) (← links)
• Three female patients with Danon disease presenting with predominant cardiac phenotype: a case series (Q90981651) (← links)
• Linking the heart and the brain: Neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia (Q91251306) (← links)
• Pulmonary vein anatomy addressed by computed tomography and relation to success of second-generation cryoballoon ablation in paroxysmal atrial fibrillation (Q91525743) (← links)